Expertise in
8
conditions

Hanna E. Seppanen

Helsinki, FI 
Expertise in
8
conditions
Helsinki, FI 

Overview

Hanna Seppanen practices practicing medicine in Helsinki, Finland.

Ms. Seppanen is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Hereditary Pancreatitis, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.

She is actively involved in clinical research, co-authoring 108 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Helsinki, Finland
Other Locations
Tampere, Finland
Oulu, Finland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Improvement of Care of Patients Undergoing Pancreaticoduodenectomy
Improvement of Care of Patients Undergoing Pancreaticoduodenectomy
Enrollment Status: Completed
Publish Date: March 14, 2025
Intervention Type: Procedure
Study Phase: Not Applicable
Cancer of the Head of the Pancreas: Early Surgery or Preoperative Biliary Drainage? A Prospective Study
Cancer of the Head of the Pancreas: Early Surgery or Preoperative Biliary Drainage? A Prospective Study
Enrollment Status: Withdrawn
Publish Date: May 20, 2021
Intervention Type: Device
Study Phase: Not Applicable
Biliary Drainage Preceding Possible Pancreaticoduodenectomy. Are Self-expandable Metallic Stents (SEMS) Superior to Plastic Stents?
Biliary Drainage Preceding Possible Pancreaticoduodenectomy. Are Self-expandable Metallic Stents (SEMS) Superior to Plastic Stents?
Enrollment Status: Withdrawn
Publish Date: May 19, 2021
Intervention Type: Device
Study Phase: Not Applicable
View 2 Less Clinical Trials

108 Total Publications

ASO Visual Abstract: Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer.
ASO Visual Abstract: Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer.
Journal: Annals of surgical oncology
Published: August 19, 2026

Frequently Asked Questions about Hanna E. Seppanen

Is Hanna E. Seppanen a top-rated expert for Pancreatic Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Hanna E. Seppanen is classified as an Distinguished expert for Pancreatic Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hanna E. Seppanen participate in research or clinical trials?

Yes. Hanna E. Seppanen has published 108 articles and abstracts on conditions like Pancreatic Cancer. You can view a list of Hanna E. Seppanen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Seppanen's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile